A Toronto gene editing company removing the DNA repeat expansions that cause inherited disease.
概要
Specific Biologics develops gene editing therapies built on its Dualase platform, which excises disease causing DNA repeat expansions. Its lead program targets the C9ORF72 repeat expansion linked to ALS.